Active

EPRESCRIPTIONS LIMITED Financials

Company number
08681796Copy
Copy
Registered office
Unit 3 Sherwood Network Centre, Sherwood Energy Village, Ollerton, Newark NG22 9FD
Incorporated
09/09/2013

Company snapshot

Status
Active
Employees
4 (2024)
Latest financial data
2024
Accounts type
Total Exemption Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2024.

Net Assets

£779.24K2024
143.00%vs 2023

2023: £-1.81M

Total Assets

£1.22M2023
224.91%vs 2022

2022: £-974.40K

Total Liabilities

£0.002024
-100.00%vs 2023

2023: £3.03M

Employees

42024
0vs 2023

2023: 4

In 2024, EPRESCRIPTIONS LIMITED reported net assets of £779.24K. The same filing shows total assets of £1.22M and total liabilities of £0.00. Reported headcount was 4 in 2024. Total Liabilities fell from £3.03M in 2023 to £0.00 in 2024 (-100.00%). Okredo holds filed figures for 2021–2024; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£779.24K2024
143.00%from £-1.81M in 2023

Year-on-year change

Net Assets as filed for 2021–2024. Every figure in this chart is also in the financial history table.

3-year financial trend (2022–2024)

How the figures EPRESCRIPTIONS LIMITED filed moved across the three reported years 2022, 2023 and 2024 — measured end to end rather than year on year.

Net Assets

£-2.93M2022£779.24K2024
Increasedvs 2022

Total Liabilities

£1.95M2022£0.002024
-100%vs 2022

Employees

4202242024
0%vs 2022

Biggest decrease

Total Liabilities-100%

£1.95M in 2022 to £0.00 in 2024

EPRESCRIPTIONS LIMITED's filings pull in both directions between 2022 and 2024. That fall came in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.

Ratios from the filed figures

Calculated from EPRESCRIPTIONS LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
-148.91%2023
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Liabilities to total assets
248.91%2023
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for EPRESCRIPTIONS LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator2021202220232024
Net Assets£-401.62K-2.93M-1.81M779.24K
Total Assets£209.36K-974.40K1.22M–
Cash in Bank£––––
Total Liabilities£610.97K1.95M3.03M0.00
Employees0444

EPRESCRIPTIONS LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Yes. Okredo holds filed figures for EPRESCRIPTIONS LIMITED covering 2021–2024, across 4 reported indicators. The most recent reported year is 2024.

EPRESCRIPTIONS LIMITED reported net assets of £779.24K for 2024. That compares with £-1.81M in 2023, a change of 143.00%.

EPRESCRIPTIONS LIMITED reported total assets of £1.22M for 2023. That compares with £-974.40K in 2022, a change of 224.91%.

EPRESCRIPTIONS LIMITED reported total liabilities of £0.00 for 2024. That compares with £3.03M in 2023, a change of -100.00%.

EPRESCRIPTIONS LIMITED reported 4 employees in 2024, compared with 4 in 2023.

Between 2022 and 2024, EPRESCRIPTIONS LIMITED's total liabilities fell by 100% and employee numbers was unchanged. Reported headcount went from 4 in 2022 to 4 in 2024. The largest fall over the period was total liabilities, down 100% from £1.95M to £0.00.

Okredo holds reported figures for the years 2021, 2022, 2023, 2024. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.